Back to Journals » Biologics: Targets and Therapy » Volume 13

Original Research

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience

       
Total article views   HTML views PDF downloads Totals
10,938 Dovepress* 10,044+ 1,879 11,923
PubMed Central* 894 362 1,256
Totals 10,938 2,241 13,179
*Since 3 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 1 8

View citations on PubMed Central and Google Scholar